acetyl l carnitine and phosphotidyle choline Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury Associated Comorbidities Frontiers | Carnitine Requires Choline

How to teach your body to learn to burn fat and not sugar

Two well-known prevention methods have been identified in the fight against cancer

This doesnt happen when you eat high folate foods ( This is concerning because high blood levels of UMFA appear to be linked to various health concerns ( Dietary folate equivalents Because folic acid is more readily absorbed than folate from food, the Food and Nutrition Board (FNB) at the National Academies of Sciences, Engineering, and Medicine have developed dietary folate equivalents (DFEs) to set clearer folate intake recommendations ( 1 mcg DFEs equals ( 1 mcg of folate from foods 0.6 mcg of folic acid from fortified foods or dietary supplements consumed with foods 0.5 mcg of folic acid from dietary supplements taken on an empty stomach There is no upper limit (UL) established for naturally occurring folate from foods

Combination Strategies for Enhanced Efficacy: For Inflammation: ALC + PEA 1,200 mg/day (demonstrated synergy in fibromyalgia)[5] ALC + Omega-3 fatty acids 2-4 g/day ALC + Curcumin 500-1,000 mg/day For Neuropathic Pain: ALC + Alpha-lipoic acid 600 mg/day (complementary metabolic support)[6] ALC + B vitamins (B1, B6, B12) for neurotrophic effects ALC + PEA for enhanced analgesic effect For Central Sensitization: ALC + PEA 1,200 mg/day (strong synergy demonstrated)[5] ALC + Magnesium 400-600 mg/day (complementary glutamate modulation) ALC + Low-dose naltrexone (complementary anti-sensitization mechanisms) For Oxidative Stress: ALC + Alpha-lipoic acid 600 mg/day ALC + N-acetylcysteine 600-1,200 mg/day ALC + CoQ10 100-300 mg/day For Mitochondrial Dysfunction: ALC + CoQ10 100-300 mg/day (complementary electron transport chain support) ALC + Alpha-lipoic acid 600 mg/day ALC + B vitamins (cofactors for mitochondrial enzymes) DOSING OVERVIEW Bioavailability: Oral bioavailability is low (14-18%) due to saturable intestinal absorption and extensive first-pass metabolism.[14][15] Despite low bioavailability, clinical efficacy is demonstrated at therapeutic doses